Dianthus Therapeutics Statistics

Total Valuation

DNTH has a market cap or net worth of $630.96 million. The enterprise value is $457.82 million.

Market Cap	630.96M
Enterprise Value	457.82M

Important Dates

The next estimated earnings date is Tuesday, May 7, 2024, before market open.

Earnings Date	May 7, 2024
Ex-Dividend Date	n/a

Share Statistics

DNTH has 29.35 million shares outstanding. The number of shares has increased by 489.48% in one year.

Shares Outstanding	29.35M
Shares Change (YoY)	+489.48%
Shares Change (QoQ)	+31.91%
Owned by Insiders (%)	15.97%
Owned by Institutions (%)	74.01%
Float	n/a

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	223.27
Forward PS	329.78
PB Ratio	3.74
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	162.00
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 18.43, with a Debt / Equity ratio of 0.00.

Current Ratio	18.43
Quick Ratio	18.09
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -34.90% and return on invested capital (ROIC) is -28.43%.

Return on Equity (ROE)	-34.90%
Return on Assets (ROA)	-32.60%
Return on Capital (ROIC)	-28.43%
Revenue Per Employee	$53,321
Profits Per Employee	-$821,792
Employee Count	53
Asset Turnover	0.02
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (1Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	25.54
200-Day Moving Average	n/a
Relative Strength Index (RSI)	37.61
Average Volume (30 Days)	169,158

Short Selling Information

The latest short interest is 1.91 million, so 6.50% of the outstanding shares have been sold short.

Short Interest	1.91M
Short Previous Month	1.39M
Short % of Shares Out	6.50%
Short % of Float	n/a
Short Ratio (days to cover)	1.19

Income Statement

In the last 12 months, DNTH had revenue of $2.83 million and -$43.56 million in losses. Loss per share was -$8.45.

Revenue	2.83M
Gross Profit	2.83M
Operating Income	-48.17M
Pretax Income	-43.56M
Net Income	-43.56M
EBITDA	-43.20M
EBIT	-43.56M
Loss Per Share	-$8.45

Full Income Statement

Balance Sheet

The company has $173.72 million in cash and $585,000 in debt, giving a net cash position of $173.13 million or $5.90 per share.

Cash & Cash Equivalents	173.72M
Total Debt	585,000
Net Cash	173.13M
Net Cash Per Share	$5.90
Equity / Book Value	168.87M
Book Value Per Share	5.75
Working Capital	167.82M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$36.86 million and capital expenditures -$110,000, giving a free cash flow of -$36.97 million.

Operating Cash Flow	-36.86M
Capital Expenditures	-110,000
Free Cash Flow	-36.97M
FCF Per Share	-$7.17

Full Cash Flow Statement

Margins

Gross margin is 100.00%, with operating and profit margins of -1,704.67% and -1,541.22%.

Gross Margin	100.00%
Operating Margin	-1,704.67%
Pretax Margin	-1,541.22%
Profit Margin	-1,541.22%
EBITDA Margin	-1,528.66%
EBIT Margin	-1,541.22%
FCF Margin	-1,308.24%

Dividends & Yields

DNTH does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-489.48%
Shareholder Yield	-489.48%
Earnings Yield	-6.90%
FCF Yield	-5.86%

Analyst Forecast

The average price target for DNTH is $41.75, which is 94.19% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$41.75
Price Target Difference	94.19%
Analyst Consensus	Strong Buy
Analyst Count	4
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on September 12, 2023. It was a reverse split with a ratio of 1:16.

Last Split Date	Sep 12, 2023
Split Type	Reverse
Split Ratio	1:16

Scores

DNTH has an Altman Z-Score of 35.57 and a Piotroski F-Score of 3.

Altman Z-Score	35.57
Piotroski F-Score	3